Shnaghai Shengkang Medical Center

2017-11-14 01:46:10 | BioPortfolio

Published on BioPortfolio: 2017-11-14T01:46:10-0500

Clinical Trials [562 Associated Clinical Trials listed on BioPortfolio]

Efficacy and Safety Study to Evaluate Gadovist (Gadobutrol) as Contrast Agent in Magnetic Resonance Imaging (MRI) of Vascular Diseases in Chinese Patients

The purpose of this study is to determine if the contrast agent is effective and safe in the Magnetic Resonance Imaging (MRI) of vascular diseases in patients of Chinese origin.

Study of ARQ 092 in Patients With Overgrowth Diseases and Vascular Anomalies

This is an open label, Phase 1/2 study of oral ARQ 092 administered to patients at least 6 years of age with overgrowth diseases and vascular anomalies with genetic alterations of the PI3K...

Expanded Access to Provide ARQ 092 for the Treatment of Overgrowth Diseases and/or Vascular Anomalies

ARQ 092 is being investigated for patients with overgrowth diseases and/or vascular anomalies with genetic alterations of the PI3K/AKT pathway and may be available for patients who are ine...

First In-human Use of SETALUM™ Sealant: The BlueSeal Clinical Study

This is a prospective, multicenter, single-arm trial to evaluate the safety and performance of SETALUM™ Sealant in sealing suture lines at the anastomosis between native vessels and synt...

Non Traumatic Neuro-Vascular Diseases Critical Complications : a Prospective Cohort Study

The purpose of this observational epidemiological study is to investigate the management and the complications associated with Non Traumatic Neuro-Vascular Diseases. Data will be analysed ...

PubMed Articles [10339 Associated PubMed Articles listed on BioPortfolio]

Functional regulation of large conductance Ca2+-activated K+ channels in vascular diseases.

The large conductance Ca2+-activated potassium channels, the BK channels, is widely expressed in various tissues and activated in a Ca2+- and voltage-dependent manner. The activation of BK channels hy...

Rare vascular diseases, building dedicated multidisciplinary specialized center.

Rare Vascular Diseases (RVD) encompass different types of vessel involvement. Some cause a dilation, others a weakening or tortuosity of the arterial wall, others an obstruction or excessive calcifica...

New models to study vascular mural cell embryonic origin: implications in vascular diseases.

A key question in vascular biology is how the diversity of origin of vascular mural cells, namely smooth muscle cells and pericytes influences vessel properties, in particular the regional propensity ...

Endothelium as a target for new therapeutic strategies in cerebral vascular diseases.

The author evaluates a role of endothelium in the pathogenesis of cerebral vascular diseases (CVD) and considers the concept about endothelium as prevention and treatment of pathological processes lea...

Predictive factors of intestinal necrosis in acute mesenteric vascular occlusive diseases.

To explore the predictive factors of intestinal necrosis in acute mesenteric vascular occlusive diseases and its significance for the timing of exploratory laparotomy.

Medical and Biotech [MESH] Definitions

Obstruction of the flow in the SPLANCHNIC CIRCULATION by ATHEROSCLEROSIS; EMBOLISM; THROMBOSIS; STENOSIS; TRAUMA; and compression or intrinsic pressure from adjacent tumors. Rare causes are drugs, intestinal parasites, and vascular immunoinflammatory diseases such as PERIARTERITIS NODOSA and THROMBOANGIITIS OBLITERANS. (From Juergens et al., Peripheral Vascular Diseases, 5th ed, pp295-6)

Loss of vascular ELASTICITY due to factors such as AGING; and ARTERIOSCLEROSIS. Increased arterial stiffness is one of the RISK FACTORS for many CARDIOVASCULAR DISEASES.

Pathological processes involving any of the BLOOD VESSELS in the cardiac or peripheral circulation. They include diseases of ARTERIES; VEINS; and rest of the vasculature system in the body.

Deposition of calcium into the blood vessel structures. Excessive calcification of the vessels are associated with ATHEROSCLEROTIC PLAQUES formation particularly after MYOCARDIAL INFARCTION (see MONCKEBERG MEDIAL CALCIFIC SCLEROSIS) and chronic kidney diseases which in turn increase VASCULAR STIFFNESS.


More From BioPortfolio on "Shnaghai Shengkang Medical Center"

Quick Search


Searches Linking to this Trial